Inspira Technologies Announces Positive Results from Clinical Study of HYLA Blood Sensor, Achieving 96% Accuracy
Inspira's AI-powered continuous blood monitoring technology demonstrated a high degree of accuracy in a key parameter, targeting multiple multi-billion-dollar market ...
Inspira Technologies Reports Full Year 2024 Financial Results and Provides Business Updates
Significant progress in HYLA blood sensor and INSPIRA ART core technologies RA'ANANA, Israel, March 11, 2025 /PRNewswire/ -- Inspira Technologies OXY B.H.N. Ltd.
Trump’s presidency: Canada’s retaliatory tariffs, Ukraine war talks and a looming government shutdown
President Donald Trump imposed a sweeping 25% tariff on all steel and aluminum imports into the United States on Wednesday, ...
Wired28d
Here’s What the FDA Label on Your Personal Care Products Means
Many of us assume that the US Food and Drug Administration approves all of our personal care products, vetting every serum, supplement, and LED mask. After all, on average, people slather on six ...
clinicaladvisor.com7d
FDA Drug Approval Decisions Expected in April 2025
The FDA is expected to decide on treatments for ... The Company is seeking approval for acute treatment of migraine with or without aura.
Monthly Prescribing Reference8d
FDA Drug Approval Decisions Expected in April 2025
The FDA is reviewing the supplemental NDA for cabozantinib ... The Company is seeking approval for acute treatment of migraine with or without aura.
FiercePharma26d
FDA approves Ono's rare tumor drug from $2.4B Deciphera buyout
A new FDA approval stands to give Daiichi Sankyo’s Turalio some company in a rare tumor type. Fellow Japanese drugmaker Ono Pharmaceutical has won an FDA green light for vimseltinib to treat ...
MedCity News29d
FDA Approval of Drug for Rare Tumors Enables SpringWorks to Challenge AstraZeneca
A genetic disease that causes tumors to form on nerves has a new FDA-approved treatment, a SpringWorks Therapeutics drug that can address a wider range of patients than the AstraZeneca product ...
Business Wire25d
FDA Approves Samsung Bioepis’ OSPOMYV™, XBRYK™ (denosumab-dssb), a Biosimilar to Prolia and Xgeva
INCHEON, Korea--(BUSINESS WIRE)--Samsung Bioepis Co., Ltd. today announced that the U.S. Food and Drug Administration (FDA) has approved the Biologics License Application (BLA) for OSPOMYV ...
Healio27d
FDA approves subcutaneous Merilog for glycemic control in diabetes
The drug, which is the first rapid-acting biosimilar, is meant to treat blood sugar spikes at mealtimes. With the approval, Merilog joins two other long-acting biosimilar insulin products.
Spineart and eCential Robotics announce FDA clearance of PERLA® App for use with Op.nTM robotic navigation platform
FOR IMMEDIATE RELEASESpineart and eCential Roboticsannounce FDA clearance of PERLA® App for use with Op.nTM robotic navigation platformDallas, ...
Science Friday27d
The FDA Approves A New, Non-Opioid Painkiller
In January, the Food and Drug Administration approved a new pain medicine called Journavx (suzetrigine), made by Vertex Pharmaceuticals. It’s the first time in 25 years the agency has given the green ...